Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lexaria Bioscience (LEXX) Non Operating Income (2022 - 2026)

Lexaria Bioscience's Non Operating Income history spans 5 years, with the latest figure at $1769.0 for Q1 2026.

  • Quarterly results put Non Operating Income at $1769.0 for Q1 2026, down 94.8% from a year ago — trailing twelve months through Feb 2026 was -$69128.0 (down 919.44% YoY), and the annual figure for FY2025 was -$30697.0, up 44.71%.
  • Non Operating Income for Q1 2026 was $1769.0 at Lexaria Bioscience, up from -$22081.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $34040.0 in Q1 2025 to a low of -$134902.0 in Q3 2023.
  • The 5-year median for Non Operating Income is -$12276.0 (2024), against an average of -$20359.7.
  • The sharpest move saw Non Operating Income tumbled 339.28% in 2024, then surged 122.89% in 2025.
  • Year by year, Non Operating Income stood at -$73887.0 in 2022, then soared by 37.88% to -$45896.0 in 2023, then soared by 65.31% to -$15921.0 in 2024, then crashed by 38.69% to -$22081.0 in 2025, then soared by 108.01% to $1769.0 in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $1769.0, -$22081.0, and -$8631.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.